Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation - Archive ouverte HAL Access content directly
Journal Articles Clinical Genitourinary Cancer Year : 2019

Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation

(1) , (1) , (1) , (1) , (1) , (2) , (2) , (2) , (1)
1
2

Domains

Life Sciences [q-bio] Human health and pathology Hépatology and Gastroenterology

Jessica Zucman-Rossi  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02532762

Submitted on : Monday, April 6, 2020-9:00:16 AM

Last modification on : Wednesday, April 8, 2020-1:47:18 AM

Not file

Dates and versions

inserm-02532762 , version 1 (06-04-2020)

Identifiers

Cite

Yana Beulque, Anne-Leen Deleu, Kevin Punie, Liesbeth de Wever, Marcella Baldewijns, et al.. Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation. Clinical Genitourinary Cancer, 2019, 17 (5), pp.e909-e912. ⟨10.1016/j.clgc.2019.06.013⟩. ⟨inserm-02532762⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-PARIS7 UNIV-PARIS13 USPC SORBONNE-PARIS-NORD UNIV-PARIS
13 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More